journal article·2021-08-15Open access

Advances in Biomaterials for Breast Reconstruction

Jun-Ho Park, Ji-Ung Park, Hak Chang

Applied Sciences· Volume 11· Issue 16

Abstract

Breast cancer is one of the most commonly diagnosed malignancies in women. Along with increasing demands for breast reconstruction, the attention given to the psychological and aesthetic benefits of breast reconstruction has also increased. As breast reconstruction and augmentation demands increase, biomaterials for breast reconstruction are being developed, and the related industry is growing quickly worldwide. Among the various biomaterials used for breast enlargement, breast implants have undergone a remarkable evolution since the 1960s. Despite unsatisfactory results and unexpected complications, research dedicated to achieving an ideal breast implant has progressed. In accordance with attention to tissue engineering, a three-dimensional (3D) bioprinting technique for breast tissue regeneration has emerged to overcome the current limitations of breast biomaterials. Along with solid implants, injectable liquid-type fillers are also part of ongoing studies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Additive Manufacturing and 3D Printing Technologies · 3D Printing in Biomedical Research · Breast Implant and Reconstruction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

SMG-SNU Boramae Medical Center, Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul 07061, Korea

Department of Plastic and Reconstructive Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul 03080, Korea

References (100+)

Show source-provided references
1. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography10.3322/canjclin.57.2.75 ↗
2. Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990–201710.1007/s10549-020-05561-1 ↗
3. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries10.1016/S0140-6736(17)33326-3 ↗
4. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study10.1001/jamaoncol.2019.2996 ↗
5. Retromammary prosthesis
6. Clinical trial and evaluation of a proposed new inflatable mammary prosthesis10.1097/00006534-197209000-00003 ↗
7. The use of inflatable breast implants10.1097/00006534-197312000-00001 ↗
8. Breast implant research: Where we have been, where we are, where we need to go10.1016/S0094-1298(20)32389-0 ↗
9. Augmentation mammaplasty10.1016/S0039-6109(16)39388-4 ↗
10. Failure properties of 352 explanted silicone-gel breast implants10.1177/229255039600400102 ↗
11. Analysis of risk factors associated with rupture of silicone gel breast implants10.1097/00006534-199909020-00009 ↗
12. Form stability of the style 410 anatomically shaped cohesive silicone gel–filled breast implant in subglandular breast augmentation evaluated with magnetic resonance imaging10.1097/PRS.0b013e3181f95aba ↗
13. Silicon in human breast tissue surrounding silicone gel prostheses: A scanning electron microscopy and energy dispersive X-ray investigation of normal, fibrocystic and peri-prosthetic breast tissue
14. Myofibroblasts and free silicon around breast implants10.1097/00006534-197808000-00006 ↗
15. Migration of silicone gel into breast parenchyma following mammary prosthesis rupture10.1007/BF01570670 ↗
16. Rupture of a silicone bag-gel breast implant by closed compression capsulotomy: Case report10.1097/00006534-197706000-00024 ↗
17. Migration of silicone gel after the” squeeze technique” to rupture a contracted breast capsule. Case report10.1097/00006534-197802000-00026 ↗
18. Histologic changes and silicone concentrations in human breast tissue surrounding silicone breast prostheses10.1097/00006534-199001000-00007 ↗
19. Post-mammoplasty connective tissue disease10.1002/art.1780250613 ↗
20. Scleroderma after silicone augmentation mammoplasty10.1001/jama.1988.03410020102037 ↗
21. Silicone and Rheumatic Diseases10.1016/0049-0172(87)90033-3 ↗
22. The basis of the FDA’s decision on breast implants10.1056/NEJM199206183262525 ↗
23. Impact of the FDA ban on silicone breast implants10.1002/jso.2930560102 ↗
24. The breast implant controversy: A clash of ethics and law10.1001/jama.1993.03510210094035 ↗
25. Knowledge, concern, and satisfaction among augmentation mammaplasty patients10.1097/00000637-199301000-00002 ↗
26. Breast implants and the FDA: Past, present, and future10.1097/00006527-199301340-00004 ↗
27. The silicone controversy—when will science prevail?10.1056/NEJM199206183262511 ↗
28. Physical characterization of unimplanted gel filled breast implants. Should old standards be revisited?
29. The Mentor study on contour profile gel silicone MemoryGel breast implants10.1097/01.prs.0000286665.91043.bc ↗
30. Natrelle style 410 form-stable silicone breast implants: Core study results at 6 years10.1177/1090820X12452423 ↗
31. Five-year follow-up data from the US clinical trial for Sientra’s US Food and Drug Administration–approved Silimed® brand round and shaped implants with high-strength silicone gel10.1097/PRS.0b013e31826b7d2f ↗
32. Textured or smooth implants for breast augmentation? A prospective controlled trial10.1016/0007-1226(91)90204-W ↗
33. Risk factor analysis for capsular contracture: A 10-year Sientra study using round, smooth, and textured implants for breast augmentation10.1097/PRS.0000000000004351 ↗
34. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: A systematic review10.1097/01.prs.0000237013.50283.d2 ↗
35. Risk factor analysis for capsular contracture: A 5-year Sientra study analysis using round, smooth, and textured implants for breast augmentation10.1097/01.prs.0000435317.76381.68 ↗
36. Early tissue reaction to textured breast implant surfaces10.1097/00000637-199204000-00010 ↗
37. How texture-inducing contraction vectors affect the fibrous capsule shrinkage around breasts implants?10.1007/s00266-010-9495-9 ↗
38. The fate of breast implants: A critical analysis of complications and outcomes10.1097/00006534-199512000-00003 ↗
39. The biomechanical and histopathologic effects of surface texturing with silicone and polyurethane in tissue implantation and expansion10.1097/00006534-199207000-00012 ↗
40. Comparative experience with smooth and polyurethane breast implants using the Kaplan-Meier method of survival analysis10.1097/00006534-199109000-00015 ↗
41. Polyurethane-coated silicone gel breast implants used for 18 years10.1007/s00266-006-0207-4 ↗
42. Long-term safety and efficacy of polyurethane foam-covered breast implants10.1016/j.asj.2006.04.001 ↗
43. Back to the future: A 15-year experience with polyurethane foam-covered breast implants using the partial-subfascial technique10.1007/s00266-011-9826-5 ↗
44. Systematic review of the effectiveness of polyurethane-coated compared with textured silicone implants in breast surgery10.1016/j.bjps.2016.01.013 ↗
45. A clinical comparison of the tendency to capsular contracture between smooth and textured gel-filled silicone mammary implants10.1097/00006534-199290020-00012 ↗
46. Rate and incidence of capsular contracture: A comparison of smooth and textured silicone double-lumen breast prostheses10.1097/00006534-199105000-00012 ↗
47. Ten-year review of a prospective randomized controlled trial of textured versus smooth subglandular silicone gel breast implants10.1097/00006534-200009020-00005 ↗
48. Antibacterial Surface Treatment for Orthopaedic Implants10.3390/ijms150813849 ↗
49. Current implant surface technology: An examination of their nanostructure and their influence on fibroblast alignment and biocompatibility
50. Preliminary 3-year evaluation of experience with SilkSurface and VelvetSurface motiva silicone breast implants: A single-center experience with 5813 consecutive breast augmentation cases10.1093/asj/sjx150 ↗
51. Covalently grafted 2-methacryloyloxyethyl phosphorylcholine networks inhibit fibrous capsule formation around silicone breast implants in a porcine model10.1021/acsami.0c07629 ↗
52. Plasma activation of a breast implant shell in conjunction with antibacterial irrigants enhances antibacterial activity10.1093/asj/sjy020 ↗
53. Evaluation of antibiotic-impregnated mesh in preventing the recurrence of capsular contracture10.1093/asj/sjy171 ↗
54. Capsular contracture in silicone gel and saline-filled breast implants after reconstruction10.1097/00006534-198402000-00022 ↗
55. Capsular contracture after breast reconstruction with silicone-gel and saline-filled implants: A 6-year follow-up10.1097/00006534-199003000-00006 ↗
56. The Mentor Core Study on Silicone MemoryGel Breast Implants10.1097/01.prs.0000286574.88752.04 ↗
57. Allergan’s silicone gel breast implants10.1586/17434440.4.5.699 ↗
58. The evolution of breast implants10.1055/s-0039-1696985 ↗
59. Silicone technology for the plastic surgeon10.1016/S0094-1298(20)31386-9 ↗
60. Clinical experience with a fourth-generation textured silicone gel breast implant: A review of 1012 Mentor MemoryGel breast implants10.1016/j.asj.2008.09.008 ↗
61. Global adverse event reports of breast implant-associated ALCL: An international review of 40 government authority databases10.1097/PRS.0000000000003233 ↗
62. Risk Factor Analysis for Capsular Contracture, Malposition, and Late Seroma in Subjects Receiving Natrelle 410 Form-Stable Silicone Breast Implants10.1097/PRS.0000000000002837 ↗
63. (2016, September 27). Breast Implants: Update on TGA Monitoring of Anaplastic Large Cell Lymphoma, Available online: https://www.tga.gov.au/alert/breast-implants-update-tga-monitoring-anaplastic-large-cell-lymphoma.
64. (2021, July 01). The FDA Requests Allergan Voluntarily Recall Natrelle BIOCELL Textured Breast Implants and Tissue Expanders from the Market to Protect Patients: FDA Safety Communication, Available online: https://www.fda.gov/medical-devices/safety-communications/fdarequests-allergan-voluntarily-recall-natrelle-biocell-texturedbreast-implants-and-tissue.
65. (2021, July 01). FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from Market, Available online: https://www.fda.gov/news-events/press-announcements/fda-takesaction-protect-patients-risk-certain-textured-breast-implantsrequests-allergan.
66. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma10.1200/JCO.2015.63.3412 ↗
67. (2021, July 01). National Comprehensive Cancer Network (NCCN). Available online: https://www.nccn.org/professionals/physician_gls/pdf/t-cell.pdf.
68. BIA-ALCL and textured breast implants: A systematic review of evidence supporting surgical risk management strategies10.1097/PRS.0000000000008040 ↗
69. How breast implant surface type is influenced by breast implant-associated anaplastic large cell lymphoma: A survey of the American Society of Plastic Surgeons10.1097/SAP.0000000000001880 ↗
70. Three-dimensional bioprinting adipose tissue and mammary Organoids feasible for artificial breast structure regeneration10.1016/j.matdes.2021.109467 ↗
71. Bioprinting technologies in tissue engineering
72. Transformation of breast reconstruction via additive biomanufacturing10.1038/srep28030 ↗
73. Additive biomanufacturing of scaffolds for breast reconstruction
74. The bioink: A comprehensive review on bioprintable materials10.1016/j.biotechadv.2016.12.006 ↗
75. Hydrogel-based 3D bioprinting: A comprehensive review on cell-laden hydrogels, bioink formulations, and future perspectives10.1016/j.apmt.2019.100479 ↗
76. Multipotency expression of human adipose stem cells in filament-like alginate and gelatin derivative hydrogel fabricated through visible light-initiated crosslinking10.1016/j.msec.2019.109808 ↗
77. Composite hydrogel scaffolds incorporating decellularized adipose tissue for soft tissue engineering with adipose-derived stem cells10.1016/j.biomaterials.2013.11.067 ↗
78. Decellularized extracellular matrix-based bioinks for engineering tissue- and organ-specific microenvironments10.1021/acs.chemrev.9b00808 ↗
79. Comparative biomechanical study of using decellularized human adipose tissues for post-mastectomy and post-lumpectomy breast reconstruction10.1016/j.jmbbm.2015.12.005 ↗
80. The use of acellular dermal matrices (ADM) in breast reconstruction: A review
81. Decellularized ECM-derived bioinks: Prospects for the future10.1016/j.ymeth.2019.04.019 ↗
82. Thomas, D.J., Jessop, Z.M., and Whitaker, I.S. (2017). 3D bioprinting adipose tissue for breast reconstruction. 3D Bioprinting for Reconstructive Surgery, Academic Press.10.1016/B978-0-08-101103-4.00034-X ↗
83. Atala, A., and Yoo, J.J. (2015). Polymers for Bioprinting. Essentials of 3D Biofabrication and Translation, Academic Press.
84. Adipose derived stem cells and platelet rich plasma improve the tissue integration and angiogenesis of biodegradable scaffolds for soft tissue regeneration10.1007/s11033-020-05297-7 ↗
85. Three-dimensionally printed breast reconstruction devices facilitate nanostructure surface-guided healthy lipogenesis10.1021/acsbiomaterials.9b00985 ↗
86. Poly(ε-caprolactone-co-p-dioxanone): A degradable and printable copolymer for pliable 3d scaffolds fabrication toward adipose tissue regeneration10.1021/acs.biomac.9b01126 ↗
87. Evaluation of polycaprolactone − poly-D, L-lactide copolymer as biomaterial for breast tissue engineering10.1002/pi.5181 ↗
88. The role of scaffold microarchitecture in engineering endothelial cell immunomodulation10.1016/j.biomaterials.2012.06.052 ↗
89. Biofunctionalization of 3D-printed silicone implants with immunomodulatory hydrogels for controlling the innate immune response: An in vivo model of tracheal defect repair10.1016/j.biomaterials.2020.120549 ↗
90. Breast augmentation with Aquafilling: Complications and radiologic features of two cases
91. Complications and radiologic features of breast augmentation via injection of aquafilling gel10.1002/jum.14527 ↗
92. Complication of ruptured poly implant prothèse breast implants combined with aquafilling gel injection: A case report and literature review10.1007/s00266-018-1242-7 ↗
93. Complication of AQUAfilling gel injection for breast augmentation: Case report of one case and review of literature10.1007/s00266-018-1107-0 ↗
94. Radiologic features of distant filler migration with inflammatory reaction following augmentation mammoplasty using aquafilling® filler
95. Imaging findings of aquafilling gel injection for breast augmentation10.1111/tbj.13682 ↗
96. Letter: Position Statement of Korean Academic Society of Aesthetic and Reconstructive Breast Surgery: Concerning the Use of Aquafilling(R) for Breast Augmentation10.14730/aaps.2016.22.1.45 ↗
97. Polyacrylamide gel injections for breast augmentation: Management of complications in 106 patients, a multicenter study10.1007/s00268-011-1273-6 ↗
98. Safety of copolyamide filler injection for breast augmentation10.1097/GOX.0000000000003296 ↗
99. Influence of different biodegradable carriers on the in vivo behavior of human adipose precursor cells10.1097/00006534-200108000-00020 ↗
100. Update on body shaping and volume restoration: The role of hyaluronic acid10.1007/s00266-020-01772-5 ↗